Association Between Polymorphisms in DNA Damage Repair Pathway Genes and Female Breast Cancer Risk

被引:1
作者
Wang, Ying [1 ,2 ]
Sun, Yalan [1 ,2 ]
Tan, Mingjuan [2 ]
Lin, Xin [2 ]
Tai, Ping [2 ]
Huang, Xiaoqin [2 ]
Jin, Qing [2 ]
Yuan, Dan [2 ]
Xu, Tao [2 ]
He, Bangshun [1 ,2 ]
机构
[1] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing, Peoples R China
[2] Nanjing Med Univ, Nanjing Hosp 1, Deparment Lab Med, Nanjing 210006, Jiangsu, Peoples R China
关键词
SNP; polymorphism; DNA damage; DDR; breast cancer; risk; SINGLE-NUCLEOTIDE POLYMORPHISMS; PROMOTER POLYMORPHISM; PALB2; SUSCEPTIBILITY; MENARCHE; VARIANTS; MECHANISMS; MENOPAUSE; GENETICS; CHINESE;
D O I
10.1089/dna.2023.0331
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Breast cancer risk have been discussed to be associated with polymorphisms in genes as well as abnormal DNA damage repair function. This study aims to assess the relationship between genes single nucleotide polymorphisms (SNPs) related to DNA damage repair and female breast cancer risk in Chinese population. A case-control study containing 400 patients and 400 healthy controls was conducted. Genotype was identified using the sequence MassARRAY method and expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2) in tumor tissues was analyzed by immunohistochemistry assay. The results revealed that ATR rs13091637 decreased breast cancer risk influenced by ER, PR (CT/TT vs. CC: adjusted odds ratio [OR] = 1.54, 95% confidence interval [CI]: 1.04-2.27, p = 0.032; CT/TT vs. CC: adjusted OR = 1.63, 95%CI: 1.14-2.35, p = 0.008) expression. Stratified analysis revealed that PALB2 rs16940342 increased breast cancer risk in response to menstrual status (AG/GG vs. AA: adjusted OR = 1.72, 95%CI: 1.13-2.62, p = 0.011) and age of menarche (AG/GG vs. AA: adjusted OR = 1.54, 95%CI: 1.03-2.31, p = 0.037), whereas ATM rs611646 and Ku70 rs132793 were associated with reduced breast cancer risk influenced by menarche (GA/AA vs. GG: adjusted OR = 0.50, 95%CI: 0.30-0.95, p = 0.033). In a summary, PALB2 rs16940342, ATR rs13091637, ATM rs611646, and Ku70 rs132793 were associated with breast cancer risk.
引用
收藏
页码:219 / 231
页数:13
相关论文
共 68 条
[1]   Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk [J].
Abd El-Fattah, Amal Ahmed ;
Sadik, Nermin Abdel Hamid ;
Shaker, Olfat Gamil ;
Kamal, Amal Mohamed .
MEDIATORS OF INFLAMMATION, 2018, 2018
[2]   The dynamics of HER2-low expression during breast cancer progression [J].
Anderson, Sarah ;
Bartow, Brooke Baxter ;
Siegal, Gene P. ;
Huang, Xiao ;
Wei, Shi .
BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (03) :437-446
[3]   microRNA-related single-nucleotide polymorphisms and breast cancer [J].
Bahreini, Farbod ;
Rayzan, Elham ;
Rezaei, Nima .
JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (03) :1593-1605
[4]   Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies [J].
Beral, V. ;
Bull, D. ;
Pirie, K. ;
Reeves, G. ;
Peto, R. ;
Skegg, D. ;
LaVecchia, C. ;
Magnusson, C. ;
Pike, M. C. ;
Thomas, D. ;
Hamajima, N. ;
Hirose, K. ;
Tajima, K. ;
Rohan, T. ;
Friedenreich, C. M. ;
Calle, E. E. ;
Gapstur, S. M. ;
Patel, A. V. ;
Coates, R. J. ;
Liff, J. M. ;
Talamini, R. ;
Chantarakul, N. ;
Koetsawang, S. ;
Rachawat, D. ;
Marcou, Y. ;
Kakouri, E. ;
Duffy, S. W. ;
Morabia, A. ;
Schuman, L. ;
Stewart, W. ;
Szklo, M. ;
Coogan, P. F. ;
Palmer, J. R. ;
Rosenberg, L. ;
Band, P. ;
Coldman, A. J. ;
Gallagher, R. P. ;
Hislop, T. G. ;
Yang, P. ;
Cummings, S. R. ;
Canfell, K. ;
Sitas, F. ;
Chao, P. ;
Lissowska, J. ;
Horn-Ross, P. L. ;
John, E. M. ;
Kolonel, L. M. ;
Nomura, A. M. Y. ;
Ghiasvand, R. ;
Hu, J. .
LANCET ONCOLOGY, 2012, 13 (11) :1141-1151
[5]   Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations? [J].
Bradbury, Alice ;
Hall, Sally ;
Curtin, Nicola ;
Drew, Yvette .
PHARMACOLOGY & THERAPEUTICS, 2020, 207
[6]   Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey [J].
Cecener, G. ;
Eskiler, G. Guney ;
Egeli, U. ;
Tunca, B. ;
Alemdar, A. ;
Gokgoz, S. ;
Tasdelen, I. .
MOLECULAR BIOLOGY REPORTS, 2016, 43 (11) :1273-1284
[7]   Association of common PALB2 polymorphisms with breast cancer risk:: A case-control study [J].
Chen, Peizhan ;
Liang, Jie ;
Wang, Zhanwei ;
Zhou, Xiaoyi ;
Chen, Lu ;
Li, Man ;
Xie, Dong ;
Hu, Zhibin ;
Shen, Hongbing ;
Wang, Hui .
CLINICAL CANCER RESEARCH, 2008, 14 (18) :5931-5937
[8]   Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications [J].
Cintolo-Gonzalez, Jessica A. ;
Braun, Danielle ;
Blackford, Amanda L. ;
Mazzola, Emanuele ;
Acar, Ahmet ;
Plichta, Jennifer K. ;
Griffin, Molly ;
Hughes, Kevin S. .
BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (02) :263-284
[9]   Methylation of progesterone receptor isoform A promoter in normal breast tissue: An epigenetic link between early age at menarche and risk of breast cancer? [J].
Daraei, Abdolreza ;
Izadi, Pantea ;
Khorasani, Ghasemali ;
Nafissi, Nahid ;
Naghizadeh, Mohammad Mehdi ;
Younosi, Nasim ;
Meysamie, Alipasha ;
Mansoori, Yaser ;
Nariman-Saleh-Fam, Ziba ;
Bastami, Milad ;
Saadatian, Zahra ;
Zendehbad, Zahra ;
Tavakkoly-Bazzaz, Javad .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (08) :12393-12401
[10]   RAD21 Amplification Epigenetically Suppresses Interferon Signaling to Promote Immune Evasion in Ovarian Cancer [J].
Deng, Peng ;
Wang, Zining ;
Chen, Jinghong ;
Liu, Shini ;
Yao, Xiaosai ;
Liu, Shaoyan ;
Liu, Lizhen ;
Yu, Zhaoliang ;
Huang, Yulin ;
Xiong, Zhongtang ;
Xiao, Rong ;
Gao, Jiuping ;
Liang, Weiting ;
Chen, Jieping ;
Liu, Hui ;
Hong, Jinghan ;
Chan, Jason Yongsheng ;
Guan, Peiyong ;
Chen, Jianfeng ;
Wang, Yali ;
Yin, Jiaxin ;
Li, Jundong ;
Zheng, Min ;
Zhang, Chao ;
Zhou, Penghui ;
Kang, Tiebang ;
Teh, Bin Tean ;
Yu, Qiang ;
Zuo, Zhixiang ;
Jiang, Qingping ;
Liu, Jihong ;
Xiong, Ying ;
Xia, Xiaojun ;
Tan, Jing .
JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (22)